Interactive Voice Response (IVR) for Methadone Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00237406|
Recruitment Status : Completed
First Posted : October 12, 2005
Last Update Posted : March 25, 2010
|Condition or disease||Intervention/treatment|
|Opioid-Related Disorders||Procedure: interactive voice response|
Participants will complete a baseline interview and a follow-up interview at 5-weeks post-baseline. Two-thirds of the participants will be randomized into the telephone call-in group, and will be asked to complete daily, 10-minute, telephone interviews. To complete these interviews, participants will call into a toll-free telephone interview system with a unique and private Study ID number, and answers questions by using the telephone key pad. Questions during both the face-to-face interviews and the telephone interviews will assess mood, sleep, treatment utilization and drug-related experiences. Participants will be compensated for their time.
Comparison(s): Participants randomized into the telephone component of the study as compared to participants in the interview-only component of the study.
|Study Type :||Observational|
|Enrollment :||50 participants|
|Official Title:||Interactive Voice Response for Methadone Patients|
|Study Start Date :||January 2006|
|Actual Study Completion Date :||October 2006|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00237406
|United States, Rhode Island|
|Rhode Island Hospital|
|Providence, Rhode Island, United States, 02903|
|Principal Investigator:||Michael D Stein, MD||Rhode Island Hospital|